Cargando…

Immune trypanolysis test as a promising bioassay to monitor the elimination of gambiense human African trypanosomiasis

The World Health Organization (WHO) has set the goal of gambiense-Human African trypanosomiasis (HAT) elimination as a public health problem for 2020 and interruption of transmission in humans for 2030. In this context, it is crucial to monitor progress towards these targets using accurate tools to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dama, Emilie, Camara, Oumou, Kaba, Dramane, Koffi, Mathurin, Camara, Mamadou, Compaoré, Charlie, Ilboudo, Hamidou, Courtin, Fabrice, Kaboré, Jacques, N’Gouan, Emmanuel Kouassi, Büscher, Philippe, Lejon, Veerle, Bucheton, Bruno, Jamonneau, Vincent
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	EDP Sciences 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6873819/ https://www.ncbi.nlm.nih.gov/pubmed/31755862 http://dx.doi.org/10.1051/parasite/2019066

Ejemplares similares

Revisiting the Immune Trypanolysis Test to Optimise Epidemiological Surveillance and Control of Sleeping Sickness in West Africa
por: Jamonneau, Vincent, et al.
Publicado: (2010)

Untreated Human Infections by Trypanosoma brucei gambiense Are Not 100% Fatal
por: Jamonneau, Vincent, et al.
Publicado: (2012)

Accuracy of Individual Rapid Tests for Serodiagnosis of Gambiense Sleeping Sickness in West Africa
por: Jamonneau, Vincent, et al.
Publicado: (2015)

Experimental evidence that immune trypanolysis using the LiTat 1.3 and LiTat 1.5 variant antigen types is not specific to Trypanosoma brucei gambiense in pigs
por: Ilboudo, Kadidiata, et al.
Publicado: (2022)

The study of trypanosome species circulating in domestic animals in two human African trypanosomiasis foci of Côte d'Ivoire identifies pigs and cattle as potential reservoirs of Trypanosoma brucei gambiense
por: N’Djetchi, Martial Kassi, et al.
Publicado: (2017)

A targeted door-to-door strategy for sleeping sickness detection in low-prevalence settings in Côte d’Ivoire
por: Koffi, Mathurin, et al.
Publicado: (2016)

Candidate gene polymorphisms study between human African trypanosomiasis clinical phenotypes in Guinea
por: Kaboré, Justin Windingoudi, et al.
Publicado: (2017)

Passive surveillance of human African trypanosomiasis in Côte d’Ivoire: Understanding prevalence, clinical symptoms and signs, and diagnostic test characteristics
por: Koné, Minayégninrin, et al.
Publicado: (2021)

Monitoring the elimination of gambiense human African trypanosomiasis in the historical focus of Batié, South–West Burkina Faso
por: Compaoré, Charlie Franck Alfred, et al.
Publicado: (2022)

The complex health seeking pathway of a human African trypanosomiasis patient in Côte d’Ivoire underlines the need of setting up passive surveillance systems
por: Koné, Minayégninrin, et al.
Publicado: (2020)

Extravascular Dermal Trypanosomes in Suspected and Confirmed Cases of gambiense Human African Trypanosomiasis
por: Camara, Mariame, et al.
Publicado: (2020)

Towards the sustainable elimination of gambiense human African trypanosomiasis in Côte d’Ivoire using an integrated approach
por: Kaba, Dramane, et al.
Publicado: (2023)

Performance of clinical signs and symptoms, rapid and reference laboratory diagnostic tests for diagnosis of human African trypanosomiasis by passive screening in Guinea: a prospective diagnostic accuracy study
por: Camara, Oumou, et al.
Publicado: (2023)

The miRNA and mRNA Signatures of Peripheral Blood Cells in Humans Infected with Trypanosoma brucei gambiense
por: Leong, Smiths, et al.
Publicado: (2013)

Correction: The miRNA and mRNA Signatures of Peripheral Blood Cells in Humans Infected with Trypanosoma brucei gambiense
por: Lueong, Smiths, et al.
Publicado: (2013)

Trypa-NO! contributes to the elimination of gambiense human African trypanosomiasis by combining tsetse control with “screen, diagnose and treat” using innovative tools and strategies
por: Ndung’u, Joseph Mathu, et al.
Publicado: (2020)

APOL1 renal risk variants have contrasting resistance and susceptibility associations with African trypanosomiasis
por: Cooper, Anneli, et al.
Publicado: (2017)

Introducing the TrypanoGEN biobank: A valuable resource for the elimination of human African trypanosomiasis
por: Ilboudo, Hamidou, et al.
Publicado: (2017)

Impact of the Ebola outbreak on Trypanosoma brucei gambiense infection medical activities in coastal Guinea, 2014-2015: A retrospective analysis from the Guinean national Human African Trypanosomiasis control program
por: Camara, Mariame, et al.
Publicado: (2017)

Do Cryptic Reservoirs Threaten Gambiense-Sleeping Sickness Elimination?
por: Büscher, Philippe, et al.
Publicado: (2018)

La Trypanosomose Humaine Africaine dans l’espace ivoiro-burkinabé : optimisation des stratégies de surveillance épidémiologique
por: Kambiré, R., et al.
Publicado: (2012)

Vers l’élimination de la maladie du sommeil
por: Solano, Philippe, et al.
Publicado: (2023)

Candidate genes-based investigation of susceptibility to Human African Trypanosomiasis in Côte d’Ivoire
por: Ahouty, Bernardin, et al.
Publicado: (2017)

Sleeping sickness in the historical focus of forested Guinea: update using a geographically based method
por: Courtin, Fabrice, et al.
Publicado: (2019)

Unravelling Human Trypanotolerance: IL8 is Associated with Infection Control whereas IL10 and TNFα Are Associated with Subsequent Disease Development
por: Ilboudo, Hamidou, et al.
Publicado: (2014)

African Trypanosomiasis Gambiense, Italy
por: Bisoffi, Zeno, et al.
Publicado: (2005)

Human host determinants influencing the outcome of Trypanosoma brucei gambiense infections
por: Bucheton, B, et al.
Publicado: (2011)

Description of the first sleeping sickness case diagnosed in Burkina Faso since two decades
por: Dama, Emilie, et al.
Publicado: (2018)

Gambiense Human African Trypanosomiasis and Immunological Memory: Effect on Phenotypic Lymphocyte Profiles and Humoral Immunity
por: Lejon, Veerle, et al.
Publicado: (2014)

Gambiense human African trypanosomiasis: the bumpy road to elimination
por: Hasker, Epco, et al.
Publicado: (2022)

Reducing Human-Tsetse Contact Significantly Enhances the Efficacy of Sleeping Sickness Active Screening Campaigns: A Promising Result in the Context of Elimination
por: Courtin, Fabrice, et al.
Publicado: (2015)

In Silico Identification of a Candidate Synthetic Peptide (Tsgf1(18–43)) to Monitor Human Exposure to Tsetse Flies in West Africa
por: Dama, Emilie, et al.
Publicado: (2013)

Performance of diagnostic tests for Trypanosoma brucei brucei in experimentally infected pigs
por: Ilboudo, Kadidiata, et al.
Publicado: (2023)

Free-ranging pigs identified as a multi-reservoir of Trypanosoma brucei and Trypanosoma congolense in the Vavoua area, a historical sleeping sickness focus of Côte d’Ivoire
por: Traoré, Barkissa Mélika, et al.
Publicado: (2021)

Accuracy of Five Algorithms to Diagnose Gambiense Human African Trypanosomiasis
por: Checchi, Francesco, et al.
Publicado: (2011)

Is vector control needed to eliminate gambiense human African trypanosomiasis?
por: Solano, Philippe, et al.
Publicado: (2013)

Monitoring the Progress towards the Elimination of Gambiense Human African Trypanosomiasis
por: Simarro, Pere P., et al.
Publicado: (2015)

Treatment options for second-stage gambiense human African trypanosomiasis
por: Eperon, Gilles, et al.
Publicado: (2014)

Village-scale persistence and elimination of gambiense human African trypanosomiasis
por: Davis, Christopher N., et al.
Publicado: (2019)

SNPs in IL4 and IFNG show no protective associations with human African trypanosomiasis in the Democratic Republic of the Congo: a case-control study
por: Fataki Asina, Olivier, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_5qim4peank9hitb8766317ehn5